Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07459556 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.
Trial Details
NCT Number NCT07459556
Lead Sponsor Chengdu Kangnuoxing Biopharma,Inc.
Conditions
(from sponsor)		 SAR
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov